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Abstract
Alcoholic liver disease has been associated with abnormalities in receptor-mediated endocytosis (RME) which results in abnormal
degradation of metabolically altered proteins. Model systems using formaldehyde-modified albumin (f-Alb) have shown an impairment in
RME following chronic alcohol consumption utilizing both in situ perfused rat livers and isolated rat liver endothelial cells (LECs). The
discovery that alcohol metabolite derived aldehydes can modify proteins prompted a study to determine if malondialdehyde–
acetaldehyde-modified albumin (MAA-Alb) would be degraded similar to that reported for f-Alb, and whether ethanol-fed rats would
demonstrate an impaired RME with respect to this ligand which occurs as a consequence of chronic ethanol consumption.
MAA-Alb was degraded slightly more than f-Alb in both in situ perfused livers and at the single cell level. This degradation was
completely inhibited with 100 unlabeled f-Alb, which suggests the use of a similar receptor. Following alcohol consumption there was a
50–60% decrease in MAA-Alb degradation in whole livers and isolated LECs. Utilizing isolated LECs it was determined that impairment
in internalization was the most likely mechanism for the decrease in the amount of MAA-Alb that was degraded. These data show that
chronic alcohol consumption by rats does in fact impair RME of alcohol metabolite-derived adducted proteins, and this impairment is due
to a defect in the post-internalization step rather than the binding or degradation of the modified protein.
# 2003 Elsevier Inc. All rights reserved.
Keywords: Receptor-mediated endocytosis; Aldehyde-modified proteins; Alcohol; Liver endothelial cells; Scavenger receptors; Protein degradation
1. Introduction
RME is a process where ligands are bound to a receptor,
internalized and shuttled to lysosomal compartments for
degradation, and then returned or expelled from the surface
of the cell [1,2]. Alteration of this process has been linked
to a number of diseases, including atherosclerosis, diabetes
mellitus, and more recently alcoholic liver disease [3–6].
RME by LECs is an important process in the elimination of
chemically modified proteins and altered macromolecules
including the following: maleylated albumin, acetylated
low density lipoprotein, malondialdehyde low density
lipoprotein, formaldehyde treated albumin, and acetalde-
hyde-modified albumin [7].
Previous studies have shown that chronic ethanol admin-
istration alters the ability of LECs to perform RME effi-
ciently. This includes the impaired degradation of both
acetaldehyde-modified proteins (AA-Alb) and f-Alb [8,9].
Tuma et al. [5] have shown that MDA and AA bind to
proteins to form a hybrid molecule termed the MAA
adduct. Antibodies to this molecule have been detected
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in the serum of alcohol-fed rats and human alcoholics
[10,11]. Taking into account that MAA-modification of
proteins at lysine residues is analogous to protein mod-
ification by other compounds, we hypothesize that MAA-
modification of proteins interferes with RME. Therefore, it
was the purpose of this study to determine whether MAA-
modified proteins are bound and degraded by in situ
perfused rat livers and to utilize isolated LECs to determine
which step in the RME process may be altered by chronic
ethanol consumption.
2. Materials and methods
2.1. Rats
Male Wistar rats purchased from Charles River Labora-
tories were maintained on a Purina rat chow diet, until they
reached a weight of 140–150 g, and were divided into three
groups. The first group was maintained ad libitum on the
standard chow diet for 5–7 weeks to serve as a control
group ensuring all results were due to ethanol, and not
another dietary factor. The second and third groups were
housed individually and acclimated to the Lieber–DeCarli
liquid control diet from Dyets, Inc. for 3 days [12]. The rats
were paired by weight, one rat was given the ethanol-
containing diet ad libitum, and the other rat was fed an
isocaloric amount of the control liquid diet as determined
by the pair-fed rat from the day before. Pair feeding was
continued for 5–7 weeks. Finally, the ethanol-containing
diet consisted of 18% of the total calories as protein, 35%
as fat, and 36% as ethanol. In the control diet, ethanol was
replaced isocalorically with carbohydrates. All animals
were allowed free access to their food and/or water up
to 1 hr before sacrifice.
2.2. Chemicals and proteins
Bovine serum albumin (Alb) was purchased from Cal-
Biochem. AA was obtained from Aldrich Chemical Co.
MDA was obtained as the sodium salt (MDA  Na) by
treatment of tetramethoxypropane (Aldrich Chemical Co.)
with NaOH, according to the method of Kikugawa and Ido
[13]. Trichloroacetic acid (TCA), phosphotungstic acid
(PTA), formaldehyde, and Percoll were purchased from
Sigma Chemical Co. Sodium 125I was purchased from
Amersham Corporation.
2.3. Preparation and labeling of ligands
Alb was labeled with 125I by the chloramine-T method
(125I-Alb), with resulting specific activities between 2800
and 3200 cpm/ng [14]. Briefly, proteins were first labeled
with 125I, and modified with formaldehyde or MAA. For-
maldehyde treatment of Alb was done using a modification
of the methods of Mego et al. [15] and Horiuchi et al. [16].
As previously described MAA-Alb was prepared by
reacting 1.0 mM AA and 1.0 mM MDA with 2 mg of
BSA in 0.1 M phosphate buffer, pH 7.2 at 378 for 3 days,
followed by dialysis against three changes of 0.1 M sodium
phosphate buffer for 24 hr at 48. The percentage of lysines
modified by the different aldehydes was determined by
the method of Habeeb [21]. Protein concentrations
were determined by the method of Lowry et al. [18],
and 125I-radioactivity was assessed using a Packard Cobra
II gamma-spectrometer.
2.4. In situ liver perfusion
After 5–7 weeks of liquid diet, rats were anesthetized
with Nembutal and perfused as previously described
[9,17]. Briefly, the liver was equilibrated for 15 min with
oxygenated Krebs–Ringer bicarbonate buffer containing
1% Alb, followed by a 2 mg/200 mL solution of 125I-
modified Alb, MAA-Alb, or f-Alb that was re-circulated
for 3 hr through the liver. At various time points, 0.5 mL
aliquots were removed and 2.0 mL of 20% TCA and 2%
PTA was added to precipitate intact proteins. Degradation
was determined by measuring the amount of acid soluble
radioactivity left in the supernatant.
2.5. Isolation of liver endothelial cells and Kupffer cells
(KCs)
LECs and KCs were prepared by perfusion and differ-
ential centrifugation methods as described previously [19].
Briefly, livers were flushed with saline containing HEPES
to remove red cells, and perfused in situ with 14 mg/
300 mL of Liberase from CalBiochem for 15 min. The
liver was removed, placed in 200 mL of Dulbecco’s phos-
phate buffered saline (D-PBS) in a sterile 250 mL flask,
and placed on a stir plate with a sterile stir bar for 30 min at
378. The suspended cells were filtered through eight ply-
type VII gauze sponges. Hepatocytes and non-parenchy-
mal cells were separated by differential centrifugation at
100 g for 5 min and 350 g for 10 min at 48. Cell pellets
were pooled, re-suspended in D-PBS, and centrifuged
through a 25%/50% Percoll gradient at 900 g for 20 min
at 48. The LECs and KCs were collected at the interface,
washed with D-PBS, and re-suspended in E-STIMTM
media (Cellgro). KCs were isolated by selective adherence
to 24-well plates for 20 min at 378, washed and placed in
10% M199/F12 media. Cells were counted on a hemocyt-
ometer and the viability was determined by trypan blue
exclusion, and found to be greater than 85% viable. Cell
purity by flow cytometry (data not shown) was found to be
greater then 90% for LECs and KCs using the following
antibodies; mouse anti-RECA-1 for endothelial cells (Ser-
otec), mouse anti-ED2 for Kupffer cells (Serotec), mouse
anti-desmin for stellate cells (Sigma), rabbit anti-rat
ASGP-receptor for hepatocytes (a generous gift from
Dr. Carol Casey, VA Medical Center, Omaha, NE) and
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Dil-Ac-LDL for endothelial cells (Biomedica Technolo-
gies Inc.).
2.6. Receptor binding assays
Receptor number was determined by the specific bind-
ing of 125I-MAA-Alb to LECs at 08. Typically, cell suspen-
sions of 1 106 cells/mL in HBSS containing 1% Alb
(HBSS-Alb) were incubated for 30 min at 378 to increase
and equilibrate the number of cell surface receptors. Cells
were kept in suspension by use of a metabolic shaker
operating at 100 rpm. Cell aliquots (typically 1 mL) were
added to 4 mL of low pH (pH 3.0) cold HBSS-Alb and
mixed gently on ice to remove any endogenously surface-
bound ligand. Samples were washed in low pH media by
centrifugation at 50 g for 3 min, the supernatant fluid
aspirated, and the cell pellet gently re-suspended in
10 mL of ice-cold wash medium and re-centrifuged. The
washed cells were then re-suspended in 2.0 mL of cold
HBSS-Alb (pH 7.4) and incubated at 08 for 60 min with
125I-MAA-Alb as described for f-Alb by Nilsson and Berg
[22]. Following incubation, samples were transferred to
tubes containing 2.5 mL of ice-cold HBSS-Alb, pelleted at
350 g for 5 min, and washed twice with 2.5 mL of ice-cold
incubation medium. These cell suspensions contained only
surface-bound 125I-MAA-Alb.
To assess specific binding of the ligand, the cell suspen-
sions were divided into two 5 mL aliquots (pH 7.4); buffer
was added to one aliquot while low pH HBSS-Alb was
added to the other. After gentle mixing on ice for 15 min,
suspensions were centrifuged, and aliquots (0.5 mL) of the
supernatant fluids were removed to determine free 125I-
MAA-Alb. Supernatant fluids were aspirated, and the
pellets were re-suspended with 5 mL of HBSS-Alb. Ali-
quots (0.5 mL) of the pellet suspension were then removed
to determine cell-associated radioactivity. Specific binding
was defined as the amount of radioactivity displaced by
low pH treatment of the cells. Low pH treatment did not
affect cell viability or the percentage of single cells. In
some cases, specific binding was assessed by including in
the binding medium an excess (100-fold) of non-radio-
active MAA-Alb. Results of specific binding were similar
for both low pH treated cells and cells incubated with
excess unlabeled ligand.
2.7. Internalization and degradation of 125I-MAA-Alb by
isolated LECs
Degradation of labeled MAA-Alb was followed by
measuring the amount of acid soluble radioactivity after
precipitating intact protein with 20% TCA/2% PTA [23].
Briefly, LEC suspensions (1 106 cells/mL) were incu-
bated at 378 for 30 min in a metabolic shaker to increase
and equilibrate the number of cell surface receptors. 125I-
MAA-Alb (100 nM, 1500 cpm/ng of protein) was added,
aliquots of the cell suspension (1 mL) were removed at
various time intervals, added to ice-cold centrifuge tubes,
and immediately centrifuged to pellet the cells. A 0.25 mL
aliquot of the supernatant was removed and added to
2.0 mL of 20% TCA/2% PTA for determination of acid
soluble radioactivity (degradation). After at least 20 min
on ice, the mixtures were centrifuged for 5 min at 350 g,
and radioactivity in the supernatant fluid was determined.
At 378 degradation of 125I-MAA-Alb was negligible in the
absence of cells.
To determine the internalization of 125I-MAA-Alb, pel-
leted and equilibrated LECs were incubated with 125I-
MAA-Alb. At various times, LECs were re-suspended
and washed twice with 1 mL of ice-cold HBSS-Alb, and
three times with HBSS-Alb at pH 3.0 to remove surface
bound ligand. After the low pH treatment, the cell suspen-
sion was centrifuged and the pellet re-suspended in
HBSS-Alb. An aliquot of this suspension (0.25 mL) was
added to 2 mL of 20% TCA/2% PTA for determination of
internalized ligand. Acid precipitates were washed 20%
TCA/2% PTA and radioactivity in the precipitated pellet
determined. This value represented the amount of intra-
cellular intact ligand. Treatment with low pH HBSS-Alb
media and subsequent centrifugation had no effect on cell
viability as assessed by exclusion by trypan blue.
2.8. Statistical analysis
Statistics were performed using ANOVA analysis com-
paring the different experimental and control groups.
Statistical significance was achieved if P values were less
than 0.05. All statistical analysis was performed using
SigmaStat (Jandel, Scientific, 1994).
3. Results
3.1. In-situ degradation of 125I-MAA-Alb
Previous studies on the degradation of f-Alb in livers of
chow-fed rats showed that 400–500 mg of 125I-f-Alb was
degraded over a 3 hr period of time [9,17]. When these
same studies were performed in ethanol rats, there was a
40–60% decrease in f-Alb degradation. Knowing that
ethanol consumption would impair f-Alb degradation,
experiments were performed to determine the effects of
ethanol on the degradation of the newly characterized
protein–MAA adduct.
As shown in Fig. 1, perfusion of chow-fed or pair-fed rat
livers with the MAA adducted Alb (that forms in the
presence of 1 mM AA with 1 mM MDA), resulted in the
degradation of approximately 450 mg of MAA-Alb over a
3 hr time period. This degradation was shown to be
decreased by 50–70% in the livers of rats chronically
consuming ethanol in their diet. Additionally, as a positive
control a little more than 400 mg of f-Alb, which has been
used previously by us [17] and others [24–27] as a standard
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ligand of the scavenger receptor, was degraded in the livers
of chow-fed rats, with a 40–50% decrease in this degrada-
tion observed in the livers of rats chronically consuming
ethanol. Aldehyde control experiments with AA-Alb and
MDA-Alb used iodinated Alb that had been exposed to
1 mmol/L of AA or MDA for 3 days at 378 and pH 7.4. As
shown in Fig. 1, AA-Alb and MDA-Alb were taken up and
degraded by the perfused liver (75 mg), at levels that were
much lower than those observed with the adduct composed
of each of these two aldehydes, MAA-Alb (400–500 mg).
Interestingly, the exposure of Alb to either of these two
aldehydes resulted in products that where <1% of the total
lysine residues available (Table 1). These data certainly
may explain the decreased ability of AA-Alb and MDA-
Alb to be degraded as compared to MAA-Alb where it was
demonstrated that 35.6% of the lysines were modified.
However, the extent of lysine modification must not be the
only factor as f-Alb (46.7%) is modified much more than
MAA-Alb, and is degraded at a slightly but significantly
lower level.
To determine whether this degradation was specific for
each ligand, the reaction was performed in the presence of
a 100 concentration of unlabeled f-Alb or MAA-Alb.
Incubation with f-Alb (100) completely inhibited the
degradation of either MAA-Alb or f-Alb indicating the
receptor(s) responsible for binding and degrading these
ligands may be similar (data not shown). Unfortunately, the
addition of 100MAA-Alb resulted in hepatotoxic effects
characterized by dissociation of liver tissue, liver leakage,
and rupture. Therefore, the liver did not remain intact and
the inhibition of 125I-MAA-Alb degradation by unlabeled
MAA-Alb was not able to be performed. This has led to
other investigations into the effects of MAA-Alb on the
liver.
To determine the kinetics of this degradation, rats were
fed for 6 weeks on pair, ethanol, and chow diets. Figure 2
shows the degradation of MAA-Alb over a 3 hr period of in
situ perfusion. Chow-fed and pair-fed animals degraded
approximately 500 mg of MAA-Alb, with the ethanol
animals degrading only about 200 mg of MAA-Alb. The
kinetics of this 60% decrease in MAA-Alb degradation
indicated that the degradation of MAA-Alb is impaired in
ethanol-fed animals similar to that observed when f-Alb
was utilized as the ligand in the perfusate [9].
3.2. Purification and characterization of LECs and KCs
Previous studies have shown that LECs or KCs are the
cells most likely involved in the degradation of these
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Fig. 1. Degradation of 125I-MAA-Alb by in situ perfused livers of chow-fed (filled bars) or ethanol-fed (empty bars) rats perfused with 10 mg/mL of 125I
labeled: MAA-Alb, f-Alb, MDA-Alb, AA-Alb, and Alb. These ligands were re-circulated via perfusion for 3 hr, aliquots taken, and TCA/PTA precipitated to
determine the amount of acid soluble protein (degradation). Experiments were performed using six animals in each group, and significance reported at
P < 0:05. Animals perfused with 125I-MAA-Alb showed significantly higher degradation than those perfused with 125I-MDA-Alb, 125I-AA-Alb, or 125I-Alb,
but not 125I-f-Alb. Additionally, chronic ethanol consumption significantly decreased the amount of degradation of every ligand except for 125I-Alb.
Table 1
Modification of lysine residues on Alb with different aldehydes
Type of
adduct
Concentration Incubation
time
Percent
modification
f-Alb 20% 1 hr 46.7
AA-Alb 1 mM 3 days <1
MDA-Alb 1 mM 3 days <1
MAA-Alb 1 mM AA þ 1 mM MDA 3 days 35.6
Note: All adducts were prepared in sealed Eppendorf tubes, wherein
2 mg of 125I-BSA was reacted with each concentration of aldehyde in
either sodium phosphate buffer (pH 7.4) or 0.2 mol/L carbonate buffer (pH
10.0) at 378 for their specific incubation time. f-Alb was produced using
20% formaldehyde. Each product was dialyzed for 16 hr against 0.02 mol/
L of sodium phosphate buffer containing 0.15 mol/L of NaCl at 48 with
several changes of the buffer. The percentage of modification of lysine
residues by the different aldehydes was determined by the method of
Habeeb [21]. P < 0:05.
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ligands. Therefore, steps were taken to isolate these cells as
described in Section 2. Using a fluorescent activated cell
sorter (FACSCalibur), LECs was found to be >90% pure by
staining with anti-RECA and Dil-Ac-LDL. Staining with
anti-ED-2 (Kupffer cell marker) showed that <5% of the
cells were Kupffer cells, with <2% of the cells staining
with anti-desmin (stellate cell marker; data not shown).
Similarly, KCs were found to be >90% pure by staining
with anti-ED-2 (Kupffer cell marker). Staining with anti-
RECA and Dil-Ac-LDL showed <5% contamination with
LECs, and <5% contamination with stellate cells (anti-
desmin). Finally, the absence of hepatocytes was confirmed
by using an antibody to the asialoglycoprotein receptor.
The purity of the LECs and KCs did not differ among
chow-fed, pair-fed or ethanol-fed rats (>90% pure).
3.3. Degradation of 125I-MAA-Alb by isolated LECs
and KCs
To determine the role of LECs in degrading 125I-MAA-
Alb, isolated cell suspensions from chow-fed, pair-fed, and
ethanol-fed animals were incubated with 25 mg of 125I-
MAA-Alb, and the amount of degradation determined by
counting the acid soluble protein in the supernatant
(Fig. 3A and B). As indicated, LECs isolated from
chow-fed and pair-fed rat livers degraded 8 mg of 125I-
MAA-Alb/106 cells (Fig. 3A). This was about 2 mg more
than observed for f-Alb [9]. However, the ability of LECs
isolated from ethanol-fed animals to degrade the protein
was decreased by 50% resulting in only 3.8 mg degraded
over the same period of time.
In contrast, KCs demonstrated the degradation of
0.0175 mg of 125I-MAA-Alb/106 cells, with no effect of
ethanol on this degradation (Fig. 3B). This degradation was
approximately 50-fold less than the amount degraded by a
similar number of LECs, and strongly suggests that the
major cells involved in the degradation of this ligand are
the LECs. Thus, the rest of the studies reported in this
manuscript will focus only on LECs.
3.4. Binding of 125I-MAA-Alb to isolated liver
endothelial cells
To compare the binding affinities for 125I-MAA-Alb
between LECs from chow-fed, pair-fed, and ethanol-fed
animals, 125I-labeled MAA-Alb was added to cell suspen-
sions as indicated in Section 2. The ability of 125I-MAA-
Alb to bind LECs from chow-fed and pair-fed rats was
similar (300 fmol/106 cells). As seen in Fig. 4, there was a
very small but statistical difference in the binding of MAA-
Alb to each of the treatment groups, indicating that the
abundance of receptor(s) and the affinity for MAA-Alb
were slightly different in the presence of ethanol in the
diet. However, this difference is not enough to result in a
50–70% decrease in degradation.
3.5. Ethanol feeding affects internalization and
degradation of 125I-MAA-Alb by isolated LECs
As shown in Fig. 5, ethanol feeding resulted in a 20–40%
decrease in 125I-MAA-Alb internalization, which was sig-
nificantly decreased between 40 and 180 min of incuba-
tion. To further determine the role of RME in the observed
ethanol-induced defect, LECs were allowed to bind the
ligand at 48 and washed three times with HBSS-Alb. The
cells were warmed to 378, aliquots of the cells harvested,
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Fig. 2. Effects of ethanol feeding on in situ degradation of 125I-MAA-Alb by livers from chow-fed (&), pair-fed (*), and ethanol-fed (~) rats. Livers were
perfused with 10 mg/mL of 125I-MAA-Alb, aliquots were taken at indicated times over a 3 hr period and intact protein precipitated with TCA/PTA. Acid
soluble radioactivity (protein degradation) in the supernatant was determined. Results are expressed as means SD (N ¼ 6 in each group) and values
significantly different from control rats at P < 0:01 are indicated.
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and the 125I-MAA-Alb that was internalized and subse-
quently degraded was determined. By performing these
studies, it was possible to trace 125I-MAA-Alb as it tra-
verses into the cell in a single round of binding, inter-
nalization, and degradation. As indicated in Fig. 6A,
internalization of surface bound ligand was decreased
by 50% in LECs from ethanol-fed animals when compared
to cells from the control groups. Additionally, the decrease
in surface bound internalization contributed to the decrease
in the percent degraded of the total surface bound ligand
(Fig. 6B), indicating that the decrease in MAA-Alb degra-
dation resulted from a defect in the internalization of
surface bound MAA-Alb. In fact, when the degradation
of MAA-Alb was normalized to the amount of surface
bound MAA-Alb (Fig. 7), there was no significant statis-
tical difference in the rate of MAA-Alb degradation
between the groups supporting the hypothesis that reduced
degradation of adducted proteins by LECs from alcohol-
fed animals results from a defect in internalization of
modified proteins and not from a reduced rate of intracel-
lular protein degradation.
4. Discussion
LECs have been shown to bind and degrade formalde-
hyde and acetaldehyde-modified proteins [8,9,17], and
chronic ethanol consumption has been shown to result
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Fig. 3. (A, B) Kinetics of 125I-MAA-Alb degradation by isolated LECs (A) and KCs (B) from chow-fed (&), pair-fed (*), and ethanol-fed (~) rats. LEC
and KC suspensions (1 106 cells/mL) were incubated at 378 with 125I-MAA-Alb (25 mg/mL of protein) for the indicated amount of time, aliquots of the cell
suspensions (1 mL) were removed, and acid-soluble radioactivity was determined as described in Section 2. Results are expressed as means SD (N ¼ 6 in
each group), and values significantly different from controls (P < 0:01) rats are indicated.
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in a significant decrease (50–60%) in the ability of LECs to
degrade these ligands. The f-Alb ligand has been used
extensively to characterize LECs as; it is almost exclu-
sively taken up by only this cell type [3,25,26]. Addition-
ally, the degradation of f-Alb has been shown to be
impaired when LECs were isolated from the livers of rats
chronically consuming ethanol, suggesting that the
removal of this ligand by RME was affected at the post-
internalization step in the process [8,9]. However, while
formaldehyde-modified proteins are readily degraded by
Concentration of MAA-Alb (µg/ml)
0 200 400 600 800 1000
fm
ol
 B
ou
nd
 / 
10
6 
L
E
C
s
0
100
200
300
400
*
*
*
Fig. 4. Binding of 125I-MAA-Alb to LECs. Cell suspensions (1 106/1.0 mL in HBSS) were incubated at 378 for 30 min to increase and stabilize the
receptor number, and then chilled on ice. One milliliter of the cold cell suspension was added to tubes containing different concentrations of 125I-MAA-Alb
(from 1 to 1000 mg/mL). Total volume was 2.0 mL. The samples were incubated at 0–48 for 90 min with constant gentle rotation, diluted with cold HBSS,
centrifuged, 0.5 mL of the supernatant fluid was removed to determine free 125I-MAA-Alb, and cell pellets were washed once with excess HBSS. Specific
binding was determined as described for binding assays in Section 2 and reported as saturation of the binding of 125I-MAA-Alb LECs isolated from chow-fed
(&), pair-fed (*), and ethanol-fed (~) rats. Specific binding was found to be 76–88% at all concentrations tested. Results are shown as the means SD for
8 determinations, and significant differences between ethanol-fed and chow- or pair-fed controls reported at P < 0:05.
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Fig. 5. Kinetics of 125I-MAA-Alb internalization by isolated LECs from chow-fed (&), pair-fed (*), and ethanol-fed (~) rats. Incubation conditions are
identical to those listed in Fig. 3. After the cell suspension was centrifuged, the medium was decanted, and the cells incubated in the presence of ice-cold
HBSS (pH 3.0) to remove surface-bound ligand. Acid-precipitable radioactivity remaining in the centrifuged cell pellet was then determined as described in
Section 2. The amount of internalized ligand was expressed as the mean SD for 6–8 determinations. Values were considered significantly different at
P < 0:01.
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LECs, their physiological relevance in disease processes
has been questioned with respect to the extent the protein is
modified, and the source of the formaldehyde. In contrast,
acetaldehyde adducts that could form following chronic
ethanol consumption are physiologically relevant, but do
not result in high levels of degradation (approximately
100 mg or less) depending upon the level of modification
[8]. Thus, the significance of impaired RME in LECs has
been, to this point, lessened by the lack of a physiological
relevant ligand (adduct).
In a report by Tuma et al. [5] it was shown that reacting
MDA and AA with proteins results in a hybrid aldehyde-
modified protein adduct that has been designated MAA.
This adduct is interesting as it forms at physiologically
relevant levels, results in a very stable and highly modified
proteins, and induces immune responses in the absence of
adjuvants. The MAA adduct has many interesting char-
acteristics that suggest it may be a good ligand for removal
by LECs. Therefore, it was the purpose of these experi-
ments to investigate how MAA-Alb is removed from the
liver, and whether chronic alcohol consumption affects this
process.
The process of a ligand binding to a specific receptor,
internalizing, and then being degraded is commonly known
as RME. Step 1 in this process is the specific binding of a
modified protein to a receptor located on the surface of the
cell. The scavenger receptor (SR) family of receptors is a
good candidate for this as they bind a number of chemi-
cally modified polyanionic compounds. Additionally,
studies by other investigators have indicated this family
of receptors are involved in the removal of a number of
modified proteins [16,20]. Step 2 in the process is the
internalization of the modified protein, and transport
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Fig. 6. (A, B) Internalization and degradation of cell surface-bound
125I-MAA-Alb by isolated LECs from chow-fed (&), pair-fed (*), and
ethanol-fed (~) rats. LEC suspensions (1 106 cells/mL in HBSS medium)
were allowed to bind to 125I-MAA-Alb at 48 as described in Section 2. The
degradation rate of cell surface-bound ligand was determined at various time
points following treatment with HBSS medium at pH 3.0 (A). Additionally,
the rate of degradation of the labeled ligand was determined as described in
Section 2 (B). Each point is the mean SD of 8 experiments. Both the
amount of cell surface-bound ligand (A) and rates of degradation (B) are
expressed as percent of the initial amount of surface-bound ligand. Values
significantly different from controls are indicated at P < 0:05.
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Fig. 7. Degradation of cell-associated 125I-MAA-Alb by LECs isolated
from chow-fed (&), pair-fed (*), and ethanol-fed (~) rats. Experimental
conditions were identical to those listed for Fig. 6. Rates of degradation of
the internalized ligand were assessed as described in Section 2. Briefly, the
rate of degradation is expressed as percent of the maximal amount of
internalized ligand for each time point. Each point is the mean SD of 8
experiments, and no significant differences (P < 0:05) were observed
between ethanol and control cells at any of the time points tested.
1052 M.J. Duryee et al. / Biochemical Pharmacology 66 (2003) 1045–1054
through the cytoplasm in endosomes to the lysosomes. The
last step is the degradation of the protein by proteolytic
enzymes in the lysosome, followed by transportation of the
degraded products out of the cell.
Previous studies by our laboratories have shown that f-
Alb and AA-Alb are degraded very efficiently by in situ
perfused rat livers [5,6,8–12], and that chronic ethanol
consumption impairs this process. Also in these studies, it
was possible to show that the removal of KCs by gadoli-
nium chloride did not alter the degradation of f-Alb or AA-
Alb in situ. Additional studies using isolated LECs or KCs,
confirmed this observation and strongly suggest that LECs
are the principle cell type in the liver capable of degrading
these modified aldehydes.
In studies described in this manuscript, isolated LECs
from chow-fed, pair-fed, and ethanol-fed rats were shown to
bind MAA-Alb through receptor(s) present on the cell sur-
face. Further analysis of the binding of MAA-Alb to LECs,
demonstrated a small but significant decrease in the binding
of this ligand to LECs from ethanol-fed rats when compared
to both control groups. Since the binding was significantly
lower, but not enough to account for the 50–60% decrease in
degradation that has been reported, it was felt that the
internalization and/or degradation of MAA-Alb must also
be altered by chronic ethanol consumption. Thus, experi-
ments were performed using a single round of MAA-Alb
binding to assess internalization and degradation. Results of
these experiments indicated a decrease in the internalization
of the surface bound ligand that is consistent with the
reported 50–60% decrease in degradation.
When the data were normalized for the amount of MAA-
Alb degraded that was actually internalized, results between
the three groups became relatively equal. This equal amount
of degradation indicated that once the protein was inter-
nalized, it was degraded. Thus, these studies demonstrated
that ethanol affects RME of MAA-Alb primarily at the post-
internalization step rather than during degradation.
In order to assure that the binding and degradation were
a result of the MAA modification of the protein; AA-Alb
and MDA-Alb were used as negative controls. In these
studies, it was shown that proteins modified with these
aldehydes at 1 mM concentrations (levels that are used to
form the MAA adduct) do not result in significant levels of
lysine modification (<1%) and are degraded very poorly
(approximately 75 mg) when compared to MAA-modifi-
cation (35.6%) and degradation (400–500 mg). Thus,
these aldehydes individually do not modify proteins very
well, and they are not efficiently recognized by the
receptors on LECs. More importantly, the combination
of these two aldehydes at the same concentration (1 mM),
can cause an increase in both the modification of the
protein and its subsequent degradation. Since both of
these aldehydes have been shown to be present during
chronic ethanol consumption, it is reasonable to believe
that the MAA adduct may have a physiologically relevant
role in aldehydes.
One point that has been difficult to investigate is the
specificity of the binding of MAA-modified proteins.
Normally, specificity is determined by inhibition with
10 or 100 cold ligand. However, in these studies
100MAA-Alb caused an alteration in the liver structure,
which resulted in the leakage of the perfusate from the liver
within a short period of time. This resulted in the loss of
ligand in the liver making it impossible to calculate binding
and degradation. With respect to isolated LECs, the cell
viability decreased in the presence of 100 MAA-Alb.
Analysis of supernatants has shown that there was an
increase in the level of tumor necrosis factor alpha (TNF-
a) into the medium following exposure to MAA-Alb (data
not shown), which could explain the cellular damage. Based
on this observation, it is enticing to speculate that impaired
RME of MAA-Alb could result in the stimulation of LECs to
release cytokines/chemokines and other inflammatory pro-
ducts. Studies are currently underway to better assess these
observations
In summary, MAA-Alb is a physiologically relevant
ligand that forms following chronic ethanol consumption
and appears to primarily be bound, internalized, and
degraded by LECs. Following chronic ethanol consumption
the ability of these cells to degrade the MAA-modified
proteins is decreased (50–60%) as a result of a defect in
both the binding and internalization processes. Regardless,
these alterations in RME may lead to a series of events by
which these products would be left in the circulation and
could: (1) stimulate LECs to release cytokine/chemokine;
and/or, (2) circulate back to lymph nodes and/or the spleen to
induce immune responses as has been previously reported.
In either case, MAA-modified proteins may induce abnor-
mal responses that could play significant roles in the devel-
opment and/or progression of alcoholic liver disease.
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